Tanzania: quality, trade issues delay HIV progress
This article was originally published in Clinica
The east African country of Tanzania is in need of "high-quality and reliable" testing for HIV infection and for detection of the stages of AIDS, according to a recently published article in the Tanzania Health Research Bulletin (Volume 9, No 1 2007). Using a 2004-05 baseline survey of 12 labs from across the country, the bulletin states that the upgrade is essential if Tanzania is to continue scaling-up its services to prevent the HIV virus and treat people infected.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.